Atlas Trials

A Study of Avastin (Bevacizumab) in Combination With Fotemustine in Patients With Metastatic Melanoma

Clinical trial NCT01069627 · COMPLETED

Trial details

NCT number
NCT01069627
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Melanoma
Start date
2006-12-01
Primary completion
2009-07-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.